Compare AU
Compare VETH vs. DRUG
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Vanguard Ethically Conscious Australian Shares ETF (VETH) and the BetaShares Global Healthcare Currency Hedged ETF (DRUG). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
VETH | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 797 | 61 |
Median incremental investment | $993.50 | $920.50 |
Median investment frequency | Monthly | Monthly |
Median total investment | $2,312.45 | $1,892.10 |
Average age group | 26 - 35 | 26 - 35 |
Key Summary
VETH | DRUG | |
|---|---|---|
Strategy | VETH.AX was created on 2020-10-12 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Ethically Conscious Australian Shares ETF seeks to track the return ofthe FTSE Australia 300 Choice Index before taking into account fees, expenses and tax. | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. |
Top 3 holdings | Commonwealth Bank of Australia (10.17 %) CSL Ltd. (9.69 %) National Australia Bank Ltd. (5.54 %) | CHF - SWISS FRANC (0 %) AUD - AUSTRALIA DOLLAR (0 %) DKK - DANISH KRONE (0 %) |
Top 3 industries | Financials (34.37 %) Materials (18.25 %) Health Care (13.54 %) | Other (75.53 %) Communication Services (33.53 %) Health Care (24.47 %) |
Top 3 countries | Australia (98.46 %) New Zealand (1.54 %) | United States (71.71 %) Switzerland (8.14 %) Denmark (6.30 %) |
Management fee | 0.17 % | 0.57 % |
Key Summary
VETH | DRUG | |
|---|---|---|
Issuer | Vanguard | BetaShares |
Tracking index | FTSE Australia 300 Choice Index | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.17 % | 0.57 % |
Price | $66.49 | $7.95 |
Size | N/A | $185.172 million |
10Y return | N/A | N/A |
Annual distribution yield (5Y) | 3.73 % | 1.90 % |
Market | ASX | ASX |
First listed date | 13/10/2020 | 08/08/2016 |
Purchase fee | $6.50 | $6.50 |
Community Stats
VETH | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 797 | 61 |
Median incremental investment | $993.50 | $920.50 |
Median investment frequency | Monthly | Monthly |
Median total investment | $2,312.45 | $1,892.10 |
Average age group | 26 - 35 | 26 - 35 |
Pros and Cons
VETH | DRUG | |
|---|---|---|
Pros |
|
|
Cons |
|
|
VETH | DRUG |
|---|---|
Higher exposure to AU market | Lower exposure to AU market |
Lower exposure to US market | Higher exposure to US market |
Lower management fee | Higher management fee |
Lower price growth | Higher price growth |
Higher distribution yield | Lower distribution yield |